While BC's status as an independent entity requires further molecular validation (e.g., whole-exome sequencing), this study highlights the necessity for international multicenter collaborations to build large-scale databases and explore chronic inflammation and immune microenvironment roles in carcinogenesis, advancing precision oncology paradigms.
Shen et al. (Sat,) studied this question.